Cargando…

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

BACKGROUND: The use of treatment planning prostate MRI for Stereotactic Body Radiation Therapy (SBRT) is largely a standard, yet not all patients can receive MRI for a variety of clinical reasons. Thus, we aim to investigate the safety of patients who received CT alone based SBRT planning for the de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amarell, Katherine, Jaysing, Anna, Mendez, Christopher, Haas, Jonathan A., Blacksburg, Seth R., Katz, Aaron E., Sanchez, Astrid, Tong, Angela, Carpenter, Todd, Witten, Matthew, Collins, Sean P., Lischalk, Jonathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977039/ https://www.ncbi.nlm.nih.gov/pubmed/35366926 http://dx.doi.org/10.1186/s13014-022-02026-1

Ejemplares similares

Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Robotic Stereotactic Body Radiation Therapy for the Adjuvant Treatment of Early-Stage Breast Cancer: Outcomes of a Large Single-Institution Study
por: Jaysing, Anna, et al.
Publicado: (2022)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
por: Blacksburg, Seth R., et al.
Publicado: (2020)

A Retrospective Review of CyberKnife Stereotactic Body Radiotherapy for Adrenal Tumors (Primary and Metastatic): Winthrop University Hospital Experience
por: Desai, Amishi, et al.
Publicado: (2015)

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
por: Leu, Justin, et al.
Publicado: (2023)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
por: Leu, Justin, et al.
Publicado: (2023)

Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT
por: Iocolano, Michelle, et al.
Publicado: (2020)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Stereotactic Body Radiation Therapy for Prostate Cancer: An Institutional Experience Using MRI-guided Treatment Planning
por: Waheed, Nabila L, et al.
Publicado: (2018)

Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report
por: Kareff, Samuel A., et al.
Publicado: (2020)

Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Aghdam, Nima, et al.
Publicado: (2021)

Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy
por: Carrasquilla, Michael, et al.
Publicado: (2021)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal–Prostate Interface and Spare the Rectum: A Case Report
por: Conroy, Dylan, et al.
Publicado: (2021)

Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer
por: Aghdam, Nima, et al.
Publicado: (2020)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
por: Lischalk, Jonathan W., et al.
Publicado: (2018)

Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Aghdam, Nima, et al.
Publicado: (2021)

Radiation Therapy for Secondary Cutaneous Plasmacytomas
por: Liu, Jerry, et al.
Publicado: (2013)

Translating the Immunobiology of SBRT to Novel Therapeutic Combinations for Advanced Prostate Cancer
por: Adorno Febles, Victor R., et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience
por: Factor, Oren B., et al.
Publicado: (2014)

Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2015)

Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Shah, Sarthak, et al.
Publicado: (2021)

Stereotactic body radiotherapy for organ-confined prostate cancer
por: Katz, Alan J, et al.
Publicado: (2010)

Long-Term Outcomes Following Conventionally Fractionated Stereotactic Boost for High-Grade Gliomas in Close Proximity to Critical Organs at Risk
por: Repka, Michael C., et al.
Publicado: (2018)

Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
por: Repka, Michael C., et al.
Publicado: (2017)

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms
por: Fega, Kathryn R., et al.
Publicado: (2018)

Prostate Stereotactic Body Radiation Therapy With Halcyon 2.0: Treatment Plans Comparison Based on RTOG 0938 Protocol
por: Altundal, Yücel, et al.
Publicado: (2020)

Stereotactic radiosurgery planning of vestibular schwannomas: Is MRI at 3 Tesla geometrically accurate?
por: Schmidt, M. A., et al.
Publicado: (2017)

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Janowski, Einsley-Marie, et al.
Publicado: (2015)

Full automation of spinal stereotactic radiosurgery and stereotactic body radiation therapy treatment planning using Varian Eclipse scripting
por: Teruel, Jose R., et al.
Publicado: (2020)

Proctitis following stereotactic body radiation therapy for prostate cancer
por: Joh, Daniel Y, et al.
Publicado: (2014)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

MRI-Related Geometric Distortions in Stereotactic Radiotherapy Treatment Planning: Evaluation and Dosimetric Impact
por: Pappas, Eleftherios P., et al.
Publicado: (2017)

Scoring system predictive of survival for patients undergoing stereotactic body radiation therapy for liver tumors
por: Kress, Marie-Adele S, et al.
Publicado: (2012)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
por: Naccarato, Stefania, et al.
Publicado: (2022)

Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
por: Solberg, Timothy D., et al.
Publicado: (2012)

[(68)Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas
por: Mahase, Sean S, et al.
Publicado: (2021)

Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma
por: Oldrini, Guillaume, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6810ismvt1s0pnf16k1791mstp